Pregabalin Sandoz GmbH Europeiska unionen - svenska - EMA (European Medicines Agency)

pregabalin sandoz gmbh

sandoz gmbh - pregabalin - anxiety disorders; epilepsy - antiepileptika, - epilepsypregabalin sandoz gmbh är indicerat som tilläggsbehandling för vuxna med partiella anfall med eller utan sekundär generalisering. generaliserad Ångest disorderpregabalin sandoz gmbh är indicerat för behandling av generaliserat ångestsyndrom (gad) hos vuxna.

Lacosamide Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Ontozry Europeiska unionen - svenska - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptika, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Lacosamide Adroiq Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Ovesterin 0,5 mg Vagitorium Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ovesterin 0,5 mg vagitorium

aspen pharma trading limited - estriol - vagitorium - 0,5 mg - estriol 0,5 mg aktiv substans - Östriol

Ovesterin 0,5 mg Vagitorium Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ovesterin 0,5 mg vagitorium

orifarm ab - estriol - vagitorium - 0,5 mg - estriol 0,5 mg aktiv substans - Östriol

Ovesterin 0,5 mg Vagitorium Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ovesterin 0,5 mg vagitorium

orifarm ab - estriol - vagitorium - 0,5 mg - estriol 0,5 mg aktiv substans - Östriol

Ovesterin 0,5 mg Vagitorium Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ovesterin 0,5 mg vagitorium

orifarm ab - estriol - vagitorium - 0,5 mg - estriol 0,5 mg aktiv substans - Östriol

Ovesterin 0,5 mg Vagitorium Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ovesterin 0,5 mg vagitorium

paranova läkemedel ab - estriol - vagitorium - 0,5 mg - estriol 0,5 mg aktiv substans - Östriol

Zycortal Europeiska unionen - svenska - EMA (European Medicines Agency)

zycortal

dechra regulatory b.v. - desoxikortonpivalat - kortikosteroider för systemisk användning - hundar - för användning som ersätter terapi för mineralkortikoid brist på hundar med primär hypoadrenocorticism (addisons sjukdom).